文献速递主动脉疾病外周动脉疾病

胸-股动脉旁路的当代结局

Contemporary outcomes of thoracofemoral bypass.
PubMed 文献 · J Vasc Surg · 2018-10-03

本研究报告2002至2017年41例因闭塞性疾病行胸-股动脉旁路(TFB)的患者,年龄61±9岁,54%为女性,7%处于高凝状态。手术死亡率为5%(n=2),主要并发症发生率为34%,估计3年主要肢体通畅率为80±10%,无主要不良肢体事件生存率为70±10%,5年生存率为93±5%。作者认为TFB在经选择的严重主髂动脉闭塞性疾病患者中可获得良好结局,支持其继续应用。

要点

  • 本组41例TFB术后30天死亡率为5%(n=2),主要并发症发生率为34%。
  • 估计3年主要肢体通畅率为80±10%,无主要不良肢体事件生存率为70±10%。
  • 估计5年生存率为93±5%,中位随访7个月(IQR 1-17个月)。

核心结论

  • 本组为迄今最大且最新的腹膜后TFB系列之一,作者认为TFB在严重主髂动脉闭塞性疾病患者中可获得良好结局,尤其当需要同期内脏/腹股沟下重建时,结果支持TFB在经选择患者中的持续作用。

研究设计与样本

  • 回顾性分析2002至2017年所有因闭塞性疾病行TFB的患者,共41例,年龄61±9岁,54%为女性,7%处于高凝状态。

主要发现

  • 术前双侧踝肱指数均值为0.4,术后双侧踝肱指数均值为0.9。
  • 手术指征包括严重肢体缺血(56%)、间歇性跛行(30%)、急性肢体缺血(7%)以及主髂动脉闭塞性疾病合并肠系膜缺血(7%)。
  • 7例(17%)既往行主-股动脉旁路,15例(38%)既往行任何主动脉手术,8例(20%)行同期内脏动脉旁路(共14条移植物:肾动脉6条、肠系膜上动脉5条、腹腔干3条)。
  • 术后住院时间为11天(IQR 7-16天),30天死亡率为5%(n=2),主要并发症发生率为34%(N=14;肺部15%、心脏12%、出血7%、意外脾切除5%、肾脏5%、伤口2%)。
  • 中位随访7个月(IQR 1-17个月)时,5例(12%)接受某种再干预(移植物/肢体相关4例,其中移植物血栓形成2例、移植物感染2例;肠系膜旁路翻修1例);估计3年主要肢体通畅率为80±10%,无主要不良肢体事件生存率为70±10%,估计5年生存率为93±5%(中位27.3;IQR 14.5-35.2;95%CI 17.9-32.8)。

关键数值与推荐

  • TFB手术方式为经左胸腹膜后途径暴露腹腔干上主动脉,离断膈脚并阻断腹腔干上主动脉,行端侧主动脉吻合,各移植物分支经腹膜后隧道引至股动脉分叉处。
  • 同期内脏/腹股沟下血运重建根据症状、终末器官功能和/或术前影像选择性进行。

临床怎么用

  • 作者认为,对于严重主髂动脉闭塞性疾病患者,尤其当需要同期内脏/腹股沟下重建时,TFB可获得良好结局,结果支持TFB在经选择患者中的持续作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thoracofemoral bypass (TFB) is an alternative to aortofemoral bypass (AFB) or extra-anatomic bypass for severe aortoiliac occlusive disease (AIOD). TFB may be particularly useful in select patients with concurrent visceral aortic branch vessel disease, infrarenal aortic occlusions, or after failed AFB. However, there are few contemporary series describing the indications and outcomes for TFB. Therefore, the purpose of this analysis was to review our experience with TFB. METHODS: All patients undergoing TFB for occlusive disease from 2002 to 2017 were reviewed. All patients underwent left thoracoretroperitoneal exposure of the supraceliac aorta with division of the diaphragmatic crus and supraceliac cross-clamping. An end-to-side aortic anastomosis was created and each graft limb was tunneled in the retroperitoneum to the femoral bifurcation. Adjunctive visceral/infrainguinal revascularization was performed selectively based on symptoms, end-organ function, and/or preoperative imaging. The primary end points were major complications and 30-day mortality. Secondary end points included limb patency, freedom from major adverse limb events, and survival. Kaplan-Meier methodology was used to characterize the end points. RESULTS: Forty-one patients (age 61 ± 9 years; 54% female; 7% in a hypercoaguable state) underwent TFB. The mean preoperative ankle-brachial index was 0.4 bilaterally. Indications included critical limb ischemia (56%), claudication (30%), acute limb ischemia (7%), and combined AIOD and mesenteric ischemia (7%). Seven patients (17%) had previously undergone AFB and 15 (38%) had previously undergone any prior aortic operation. Adjunctive visceral bypass occurred in 8 patients (20%; N = 14 grafts, n = 6 renal, n = 5 superior mesenteric artery, and n = 3 celiac). The postoperative duration of stay was 11 days (interquartile range [IQR], 7-16 days) and the 30-day mortality was 5% (n = 2). Major complications occurred in 34% of patients (N = 14; pulmonary, 15%; cardiac, 12%; bleeding, 7%; accidental splenectomy, 5%; renal, 5%; wound, 2%). The mean postoperative ankle-brachial index was 0.9 bilaterally. At a median follow-up of 7 months (IQR, 1-17 months), 5 patients (12%) underwent some form of reintervention (graft/limb related, n = 4 [n = 2 graft thrombosis, n = 2 graft infection], n = 1 mesenteric bypass revision). The estimated 3-year primary limb patency and freedom from major adverse limb events were 80 ± 10%, and 70 ± 10%, respectively. The estimated 5-year survival was 93 ± 5% (median, 27.3; IQR, 14.5-35.2; 95% confidence interval, 17.9-32.8). CONCLUSIONS: This experience represents one of the largest and most current series of retroperitoneal TFB. We demonstrate that TFB can be performed with good outcomes for patients with severe AIOD, especially if concomitant visceral/infrainguinal reconstruction is warranted. These results support a continued role for TFB in select patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Crawford JD, Scali ST, Giles KA, et al. Contemporary outcomes of thoracofemoral bypass. J Vasc Surg. 2018. PMID: 30292606. doi:10.1016/j.jvs.2018.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。